Skip to main content

Call for Papers: Tackling Drug Resistance in Ovarian Cancer: Mechanisms, Biomarkers, and Emerging Therapeutics


Edited by: 

Murali Yallapu, PhD, The University of Texas Rio Grande Valley, United States
Sham S. Kakar, PhD, University of Louisville, United States
Submission Status: Open until 4 March 2026

Call for Papers: Microbiome in Reproductive Health, Dysfunction, and Cancer

New Content Item

Edited by:
Professor Julang Li, PhD, University of Guelph, Canada
Svetlana Madjunkova, MD, PHD, CReATe Fertility Centre, Canada
Professor Ofer Reizes, MD, PhD, Cleveland Clinic, United States of America
Submission Status: Open until 1 July 2025

Articles

World Ovarian Cancer Day 2025

New Content Item

Join us in commemorating World Ovarian Cancer Day on May 8th with a look back at relevant articles and collections published in Journal of Ovarian Research on ovarian cancer.

Aims and scope

Journal of Ovarian Research is an open access, peer reviewed, online journal that aims to provide a forum for high-quality basic and clinical research on ovarian function, abnormalities, and cancer. The journal focuses on research that provides new insights into ovarian functions as well as prevention and treatment of diseases afflicting the organ.

Topical areas include, but are not restricted to:

  • Ovary development, hormone secretion and regulation
  • Follicle growth and ovulation
  • Infertility and Polycystic ovarian syndrome
  • Regulation of pituitary and other biological functions by ovarian hormones
  • Ovarian cancer, its prevention, diagnosis and treatment
  • Drug development and screening
  • Role of stem cells in ovary development and function

Featured Collection: Nanotechnological Approaches for the Treatment of Ovarian Cancer


Edited by:
Rajesh Singh: PhD, Morehouse School of Medicine, USA
Submission Status: Closed

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.8
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 0.957
    SCImago Journal Rank (SJR): 0.968

    Speed 2024
    Submission to first editorial decision (median days): 8
    Submission to acceptance (median days): 124

    Usage 2024
    Downloads: 1,443,643
    Altmetric mentions: 320

News

New Content ItemEditor-in-Chief Dr Ben Tsang has been selected as a 2025 Distinguished Fellow by the Society for the Study of Reproduction (SSR) Awards Committee. Please join us in celebrating this amazing achievement. 

A new FDA approved phase I/II clinical trial on recurrent ovarian cancer is now open for enrollment.

Currently recruiting patients at the Brown Cancer Center, University of Louisville, Louisville, KY. UofL. IRB# 22.0392. NCT# 05610735. Please contact: Dr. Whitney Goldsberry or Dr. Sham S. Kakar.

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.